Benzo(1,2,5)oxadiazoles and benzo (1,2,5)thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers

Details for Australian Patent Application No. 2004226216 (hide)

Owner Novartis AG

Inventors Auberson, Yves; Zimmermann, Kaspar; Hintermann, Samuel

Agent Davies Collison Cave

Pub. Number AU-A-2004226216

PCT Pub. Number WO2004/087684

Priority 0307855.7 04.04.03 GB

Filing date 2 April 2004

Wipo publication date 14 October 2004

International Classifications

C07D 271/12 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 285/14 Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

A61K 051/04 Preparations containing radioactive substances for use in therapy or testing

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/087684 Priority application(s): WO2004/087684

18 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226226-Thin coating aluminum pigments, method for the production thereof, and use of said aluminum pigments

2004226215-Oxime derivatives and their use as pharmaceutically active agents